Form 4 for CGON CG Oncology, Inc.
Accepted 2025-10-15 00:00:00 ET · period of report 2025-10-13 · accession 0001193125-25-240271 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-10-15 | 2025-10-13 | CGON | POST LEONARD E | Dir | S - Sale+OE | $43.25 | -1,000 | 0 | -100% | -$43.2K |
| DT | 2025-10-15 | 2025-10-13 | CGON | POST LEONARD E | Dir | M - OptEx | $0.6 | +1,000 | 1,000 | New | +$600 |
| DT | 2025-10-15 | 2025-10-13 | CGON | POST LEONARD E | Dir | M - OptEx | $0.00 | -1,000 | 118.1K | -0.8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-13 | S | D | 1,000 | $43.25 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-10-13 | M | A | 1,000 | $0.6 | 1,000 | D | — | — | |
| 3 | Derivative | Director Stock Option (right to buy) | 2025-10-13 | M | D | 1,000 | $0.00 | 118,077 | D | $0.6 · — to 2028-07-08 | 1,000 Common Stock | (F2) Fully vested |